ID   KPCL_RAT                Reviewed;         683 AA.
AC   Q64617;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   24-JUL-2024, entry version 193.
DE   RecName: Full=Protein kinase C eta type;
DE            EC=2.7.11.13;
DE   AltName: Full=PKC-L;
DE   AltName: Full=nPKC-eta;
GN   Name=Prkch; Synonyms=Pkch;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Lung;
RX   PubMed=1426252; DOI=10.1016/0014-5793(92)80934-9;
RA   Dekker L.V., Parker P.J., McIntyre P.;
RT   "Biochemical properties of rat protein kinase C-eta expressed in COS
RT   cells.";
RL   FEBS Lett. 312:195-199(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-656 AND SER-675, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-
CC       dependent serine/threonine-protein kinase that is involved in the
CC       regulation of cell differentiation in keratinocytes and pre-B cell
CC       receptor, mediates regulation of epithelial tight junction integrity
CC       and foam cell formation, and is required for glioblastoma proliferation
CC       and apoptosis prevention in MCF-7 cells. In keratinocytes, binds and
CC       activates the tyrosine kinase FYN, which in turn blocks epidermal
CC       growth factor receptor (EGFR) signaling and leads to keratinocyte
CC       growth arrest and differentiation. Associates with the cyclin CCNE1-
CC       CDK2-CDKN1B complex and inhibits CDK2 kinase activity, leading to RB1
CC       dephosphorylation and thereby G1 arrest in keratinocytes. In
CC       association with RALA activates actin depolymerization, which is
CC       necessary for keratinocyte differentiation. In the pre-B cell receptor
CC       signaling, functions downstream of BLNK by up-regulating IRF4, which in
CC       turn activates L chain gene rearrangement. Regulates epithelial tight
CC       junctions (TJs) by phosphorylating occludin (OCLN) on threonine
CC       residues, which is necessary for the assembly and maintenance of TJs.
CC       In association with PLD2 and via TLR4 signaling, is involved in
CC       lipopolysaccharide (LPS)-induced RGS2 down-regulation and foam cell
CC       formation. Upon PMA stimulation, mediates glioblastoma cell
CC       proliferation by activating the mTOR pathway, the PI3K/AKT pathway and
CC       the ERK1-dependent phosphorylation of ELK1. Involved in the protection
CC       of glioblastoma cells from irradiation-induced apoptosis by preventing
CC       caspase-9 activation. In camptothecin-treated MCF-7 cells, regulates
CC       NF-kappa-B upstream signaling by activating IKBKB, and confers
CC       protection against DNA damage-induced apoptosis. Promotes oncogenic
CC       functions of ATF2 in the nucleus while blocking its apoptotic function
CC       at mitochondria. Phosphorylates ATF2 which promotes its nuclear
CC       retention and transcriptional activity and negatively regulates its
CC       mitochondrial localization (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.13;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.13;
CC   -!- ACTIVITY REGULATION: Novel PKCs (PRKCD, PRKCE, PRKCH and PRKCQ) are
CC       calcium-insensitive, but activated by diacylglycerol (DAG) and
CC       phosphatidylserine. Three specific sites; Thr-513 (activation loop of
CC       the kinase domain), Thr-656 (turn motif) and Ser-675 (hydrophobic
CC       region), need to be phosphorylated for its full activation.
CC   -!- SUBUNIT: Interacts with FYN (By similarity). Interacts with RALA (By
CC       similarity). Interacts with DGKQ (By similarity).
CC       {ECO:0000250|UniProtKB:P23298, ECO:0000250|UniProtKB:P24723}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- DOMAIN: The C1 domain, containing the phorbol ester/DAG-type region 1
CC       (C1A) and 2 (C1B), is the diacylglycerol sensor and the C2 domain is a
CC       non-calcium binding domain.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X68400; CAA48466.1; -; mRNA.
DR   EMBL; BC081782; AAH81782.1; -; mRNA.
DR   PIR; I60246; S29478.
DR   RefSeq; NP_112347.1; NM_031085.2.
DR   AlphaFoldDB; Q64617; -.
DR   SMR; Q64617; -.
DR   BioGRID; 249621; 4.
DR   STRING; 10116.ENSRNOP00000006729; -.
DR   BindingDB; Q64617; -.
DR   ChEMBL; CHEMBL2094266; -.
DR   DrugCentral; Q64617; -.
DR   iPTMnet; Q64617; -.
DR   PhosphoSitePlus; Q64617; -.
DR   PaxDb; 10116-ENSRNOP00000006729; -.
DR   Ensembl; ENSRNOT00000006729.8; ENSRNOP00000006729.7; ENSRNOG00000004873.8.
DR   Ensembl; ENSRNOT00055015282; ENSRNOP00055012241; ENSRNOG00055009031.
DR   Ensembl; ENSRNOT00060010597; ENSRNOP00060007853; ENSRNOG00060006464.
DR   Ensembl; ENSRNOT00065010649; ENSRNOP00065007870; ENSRNOG00065006836.
DR   GeneID; 81749; -.
DR   KEGG; rno:81749; -.
DR   UCSC; RGD:621888; rat.
DR   AGR; RGD:621888; -.
DR   CTD; 5583; -.
DR   RGD; 621888; Prkch.
DR   eggNOG; KOG0694; Eukaryota.
DR   GeneTree; ENSGT00940000158220; -.
DR   HOGENOM; CLU_000288_54_4_1; -.
DR   InParanoid; Q64617; -.
DR   OMA; MTKNPNM; -.
DR   OrthoDB; 841660at2759; -.
DR   PhylomeDB; Q64617; -.
DR   TreeFam; TF351133; -.
DR   BRENDA; 2.7.11.13; 5301.
DR   Reactome; R-RNO-114508; Effects of PIP2 hydrolysis.
DR   PRO; PR:Q64617; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Bgee; ENSRNOG00000004873; Expressed in lung and 18 other cell types or tissues.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004699; F:diacylglycerol-dependent, calcium-independent serine/threonine kinase activity; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0120283; F:protein serine/threonine kinase binding; ISO:RGD.
DR   GO; GO:0030291; F:protein serine/threonine kinase inhibitor activity; ISO:RGD.
DR   GO; GO:0031267; F:small GTPase binding; ISO:RGD.
DR   GO; GO:0045182; F:translation regulator activity; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0034351; P:negative regulation of glial cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0017148; P:negative regulation of translation; ISO:RGD.
DR   GO; GO:0050861; P:positive regulation of B cell receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060252; P:positive regulation of glial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0045618; P:positive regulation of keratinocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; ISS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0032056; P:positive regulation of translation in response to stress; ISO:RGD.
DR   GO; GO:0070528; P:protein kinase C signaling; IMP:RGD.
DR   GO; GO:2000810; P:regulation of bicellular tight junction assembly; ISS:UniProtKB.
DR   CDD; cd20835; C1_nPKC_epsilon-like_rpt1; 1.
DR   CDD; cd20838; C1_nPKC_epsilon-like_rpt2; 1.
DR   CDD; cd04014; C2_PKC_epsilon; 1.
DR   CDD; cd05590; STKc_nPKC_eta; 1.
DR   Gene3D; 3.30.60.20; -; 2.
DR   Gene3D; 2.60.40.150; C2 domain; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR034665; nPKC_eta.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR027431; PKC_eta.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR014376; Prot_kin_PKC_delta.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24351:SF198; PROTEIN KINASE C ETA TYPE; 1.
DR   PANTHER; PTHR24351; RIBOSOMAL PROTEIN S6 KINASE; 1.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000551; PKC_delta; 1.
DR   PIRSF; PIRSF501107; Protein_kin_C_eta; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; Cytoplasm; Differentiation; Kinase; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase; Zinc; Zinc-finger.
FT   CHAIN           1..683
FT                   /note="Protein kinase C eta type"
FT                   /id="PRO_0000055707"
FT   DOMAIN          1..118
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          355..614
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          615..683
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   ZN_FING         171..222
FT                   /note="Phorbol-ester/DAG-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ZN_FING         245..295
FT                   /note="Phorbol-ester/DAG-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ACT_SITE        479
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         361..369
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         384
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         28
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P24723"
FT   MOD_RES         32
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P24723"
FT   MOD_RES         317
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P23298"
FT   MOD_RES         513
FT                   /note="Phosphothreonine; by PDPK1"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         656
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         675
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   683 AA;  77947 MW;  2F5B7078D1206510 CRC64;
     MSSGTMKFNG YLRVRIGEAV GLQPTRWSLR HSLFKKGHQL LDPYLTVSVD QVRVGQTSTK
     QKTNKPTYNE EFCTNVSDGG HLELAVFHET PLGYDHFVAN CTLQFQELLR TAGTSDTFEG
     WVDLEPEGKV FVVITLTGSF TEATLQRDRI FKHFTRKRQR AMRRRVHQVN GHKFMATYLR
     QPTYCSHCRE FIWGVFGKQG YQCQVCTCVV HKRCHHLIVT ACTCQNNINK VDAKIAEQRF
     GINIPHKFNV HNYKVPTFCD HCGSLLWGIM RQGLQCKICK MNVHIRCQAN VAPNCGVNAV
     ELAKTLAGMG LQPGNISPTS KLISRSTLRR QGKEGSKEGN GIGVNSSSRF GIDNFEFIRV
     LGKGSFGKVM LARIKETGEL YAVKVLKKDV ILQDDDVECT MTEKRILSLA RNHPFLTQLF
     CCFQTPDRLF FVMEFVNGGD LMFHIQKSRR FDEARARFYA AEIISALMFL HEKGIIYRDL
     KLDNVLLDHE GHCKLADFGM CKEGICNGVT TATFCGTPDY IAPEILQEML YGPAVDWWAM
     GVLLYEMLCG HAPFEAENED DLFEAILNDE VVYPTWLHED ATGILKSFMT KNPTMRLGSL
     TQGGEHEILR HPFFKEIDWV QLNHRQLEPP FRPRIKSRED VSNFDPDFIK EEPVLTPIDE
     GHLPMINQDE FRNFSYVSPE LQP
//
